Deucravacitinib by Bristol-Myers Squibb can help with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and systemic lupus erythematosus.
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
Pilocarpine by Allergan and AbbVie is the first drug for age-related farsightedness.
The pharmaceutical industry continues to fight hard against the devastating neurodegenerative disease.
Oral ozanimod will provide clinical remission of ulcerative colitis for a third of patients.
In the task of getting rid of headaches lasmiditan by Eli Lilly is as effective as the popular triptans, but safer.
Cheating out of ignorance, or Sleight of hand and no fraud. How pharmaceutical companies scam clinical trials.